188 related articles for article (PubMed ID: 3034150)
1. Antiviral activity of glycyrrhizin against varicella-zoster virus in vitro.
Baba M; Shigeta S
Antiviral Res; 1987 Feb; 7(2):99-107. PubMed ID: 3034150
[TBL] [Abstract][Full Text] [Related]
2. [Antiviral effect of glycyrrhizin on varicella-zoster virus replication in vitro].
Baba M; Shigeta S
Kansenshogaku Zasshi; 1986 Sep; 60(9):1048-51. PubMed ID: 3027210
[No Abstract] [Full Text] [Related]
3. Inhibitory effects of selected antiviral compounds on newly isolated clinical varicella-zoster virus strains.
Baba M; Konno K; Shigeta S; De Clercq E
Tohoku J Exp Med; 1986 Mar; 148(3):275-83. PubMed ID: 3010502
[TBL] [Abstract][Full Text] [Related]
4. Influence of various experimental conditions on the inhibitory effects of (E)-5-(2-bromovinyl)-2'-deoxyuridine on varicella-zoster virus replication in cell culture.
Baba M; Shigeta S; De Clercq E
Tohoku J Exp Med; 1984 Aug; 143(4):441-9. PubMed ID: 6093286
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory activity of oxyresveratrol on wild-type and drug-resistant varicella-zoster virus replication in vitro.
Sasivimolphan P; Lipipun V; Likhitwitayawuid K; Takemoto M; Pramyothin P; Hattori M; Shiraki K
Antiviral Res; 2009 Oct; 84(1):95-7. PubMed ID: 19635502
[TBL] [Abstract][Full Text] [Related]
6. Studies on mechanism of action of glycyrrhizin against hepatitis A virus replication in vitro.
Crance JM; Lévêque F; Biziagos E; van Cuyck-Gandré H; Jouan A; Deloince R
Antiviral Res; 1994 Jan; 23(1):63-76. PubMed ID: 8141593
[TBL] [Abstract][Full Text] [Related]
7. Antiviral activity of liquorice powder extract against varicella zoster virus isolated from Egyptian patients.
Shebl RI; Amin MA; Emad-Eldin A; Bin Dajem SM; Mostafa AS; Ibrahim EH; Mohamed AF
Chang Gung Med J; 2012; 35(3):231-9. PubMed ID: 22735054
[TBL] [Abstract][Full Text] [Related]
8. Comparative efficacy of antiherpes drugs against various strains of varicella-zoster virus.
Shigeta S; Yokota T; Iwabuchi T; Baba M; Konno K; Ogata M; De Clercq E
J Infect Dis; 1983 Mar; 147(3):576-84. PubMed ID: 6300257
[TBL] [Abstract][Full Text] [Related]
9. Synergistic anti-varicella-zoster virus activity of interferon-alpha 2a and acyclovir in corneal cells.
Punda-Polić V; O'Brien WJ; Taylor JL
Zentralbl Bakteriol; 1999 Apr; 289(2):203-10. PubMed ID: 10360320
[TBL] [Abstract][Full Text] [Related]
10. Role of the protein kinase PKR in the inhibition of varicella-zoster virus replication by beta interferon and gamma interferon.
Desloges N; Rahaus M; Wolff MH
J Gen Virol; 2005 Jan; 86(Pt 1):1-6. PubMed ID: 15604425
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of inhibitory effect of glycyrrhizin on replication of human immunodeficiency virus (HIV).
Ito M; Sato A; Hirabayashi K; Tanabe F; Shigeta S; Baba M; De Clercq E; Nakashima H; Yamamoto N
Antiviral Res; 1988 Dec; 10(6):289-98. PubMed ID: 3250333
[TBL] [Abstract][Full Text] [Related]
12. Synergistic antiviral effects of antiherpes compounds and human leukocyte interferon on varicella-zoster virus in vitro.
Baba M; Ito M; Shigeta S; De Clercq E
Antimicrob Agents Chemother; 1984 Apr; 25(4):515-7. PubMed ID: 6329083
[TBL] [Abstract][Full Text] [Related]
13. Antiviral bioactivity of renewable polysaccharides against
Abu-Galiyun E; Huleihel M; Levy-Ontman O
Cell Cycle; 2019 Dec; 18(24):3540-3549. PubMed ID: 31724465
[TBL] [Abstract][Full Text] [Related]
14. Utility of ultra-deep sequencing for detection of varicella-zoster virus antiviral resistance mutations.
Mercier-Darty M; Boutolleau D; Lepeule R; Rodriguez C; Burrel S
Antiviral Res; 2018 Mar; 151():20-23. PubMed ID: 29337163
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine against newly isolated clinical varicella-zoster virus strains.
Baba M; Konno K; Shigeta S; De Clercq E
Eur J Clin Microbiol; 1987 Apr; 6(2):158-60. PubMed ID: 3036498
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of glycyrrhizin on the in vitro infectivity and cytopathic activity of the human immunodeficiency virus [HIV (HTLV-III/LAV)].
Ito M; Nakashima H; Baba M; Pauwels R; De Clercq E; Shigeta S; Yamamoto N
Antiviral Res; 1987 Mar; 7(3):127-37. PubMed ID: 3475037
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of DNA synthesis in varicella-zoster virus-infected cells by BV-araU.
Machida H; Watanabe Y
Microbiol Immunol; 1991; 35(2):139-45. PubMed ID: 1653394
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the selectivity of anti-varicella-zoster virus nucleoside analogues.
Machida H; Nishitani M; Watanabe Y; Yoshimura Y; Kano F; Sakata S
Microbiol Immunol; 1995; 39(3):201-6. PubMed ID: 7603364
[TBL] [Abstract][Full Text] [Related]
19. Antiviral activity of propolis special extract GH 2002 against
Labská K; Plodková H; Pumannová M; Sensch KH
Pharmazie; 2018 Dec; 73(12):733-736. PubMed ID: 30522559
[TBL] [Abstract][Full Text] [Related]
20. ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2.
Chono K; Katsumata K; Kontani T; Kobayashi M; Sudo K; Yokota T; Konno K; Shimizu Y; Suzuki H
J Antimicrob Chemother; 2010 Aug; 65(8):1733-41. PubMed ID: 20534624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
